Compare Nippon India Pharma Fund vs SBI Healthcare Opportunities Fund
Risk | Very High | Very High |
Rating | 3.0 | 4.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 1.82 | 1.93 |
NAV | ₹518.61 | ₹423.95 |
Fund Started | 10 May 2004 | 04 Jun 1999 |
Fund Size | ₹8458.68 Cr | ₹4130.76 Cr |
Exit Load | Exit load of 1% if redeemed within 1 month. | Exit load of 0.50% if redeemed within 15 days |
Risk
Very High
Very High
Rating
3.0
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
1.82
1.93
NAV
₹518.61
₹423.95
Fund Started
10 May 2004
04 Jun 1999
Fund Size
₹8458.68 Cr
₹4130.76 Cr
Exit Load
Exit load of 1% if redeemed within 1 month.
Exit load of 0.50% if redeemed within 15 days
1 Year | -2.90% | -3.64% |
3 Year | 21.75% | 24.07% |
5 Year | 14.55% | 16.39% |
1 Year
-2.90%
-3.64%
3 Year
21.75%
24.07%
5 Year
14.55%
16.39%
Equity | 99.47% | 95.82% |
Cash | 0.53% | 4.11% |
Equity
99.47%
95.82%
Cash
0.53%
4.11%
Top 10 Holdings |
|
|
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 13.55% |
Lupin Ltd. | 7.59% |
Divi's Laboratories Ltd. | 6.90% |
Cipla Ltd. | 6.33% |
Dr. Reddy's Laboratories Ltd. | 5.83% |
Apollo Hospitals Enterprise Ltd. | 5.63% |
Medplus Health Services Ltd. | 3.47% |
Vijaya Diagnostic Centre Ltd. | 3.41% |
Ajanta Pharma Ltd. | 2.90% |
Glaxosmithkline Pharmaceuticals Ltd. | 2.77% |
Sun Pharmaceutical Industries Ltd. | 11.97% |
Divi's Laboratories Ltd. | 6.90% |
Max Healthcare Institute Ltd. | 5.63% |
Cipla Ltd. | 4.45% |
Lupin Ltd. | 4.23% |
Lonza Group Ag | 4.01% |
Acutaas Chemicals Ltd. | 4.00% |
Torrent Pharmaceuticals Ltd. | 3.60% |
Laurus Labs Ltd. | 3.50% |
Fortis Healthcare Ltd. | 3.34% |
Name | - | - |
Start Date | - | - |
Name
-
-
Start Date
-
-
Description | The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 10 May 2004 | 04 Jun 1999 |
Description
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
10 May 2004
04 Jun 1999